Wilate



Wilate

Product Specs Wilate
Manufacturer Name Octapharma
Indications Children and adults with von Willebrand disease for:

  • On-demand treatment and control of bleeding episodes
  • Perioperative management of bleeding

    • Adolescents and adults with hemophilia A for:

  • Routine prophylaxis to reduce the frequency of bleeding episodes
  • On-demand treatment and control of bleeding
    		•
    Contraindications Patients with known hypersensitivity reactions, including anaphylactic or severe system reactions, to human plasma-derived product, any ingredient in the formulation, or components of the container.
    Ratio of VWF: RCO to FVIII 1:1
    Viral Safety Process Ion-exchange chromatography; solvent/detergent treatment, and terminal dry-heat treatment
    Product Half-Life Adolescents – Mean: 11.41 (range: 9.37-14.57)
    Adults – Mean: 10.64 (range: 6.30-15.43)
    Product Recovery Percentage Adolescents – 1.66% per IU/kg
    Adults – 2.27% per IU/kg
    Manufacturing Methods Plasma Derived
    Storage Requirements
  • Refrigerated at 2°C to 8°C (36°F to 46°F) or at room temperature up to 25°C (77°F).
  • Do not freeze.
  • Protect from light.
    		•
    Shelf Life 36 months from manufactured date
    6 months at room temperature
    Nominal Vial Size & Diluent Volume 500 IU VWF:RCo, 500 IU FVIII:C/5 mL
    1000 IU VWF:RCo, 1000 IU FVIII:C/10 mL


    Return to Manufacturer Name listing Return to Factor Type listing